140 related articles for article (PubMed ID: 17196552)
1. Melanotransferrin induces human melanoma SK-Mel-28 cell invasion in vivo.
Bertrand Y; Demeule M; Michaud-Levesque J; Béliveau R
Biochem Biophys Res Commun; 2007 Feb; 353(2):418-23. PubMed ID: 17196552
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of melanoma brain metastasis by targeting melanotransferrin at the cell surface.
Rolland Y; Demeule M; Fenart L; Béliveau R
Pigment Cell Melanoma Res; 2009 Feb; 22(1):86-98. PubMed ID: 19017294
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of cell surface plasminogen activation by membrane-bound melanotransferrin: a key phenomenon for cell invasion.
Michaud-Levesque J; Demeule M; Béliveau R
Exp Cell Res; 2005 Aug; 308(2):479-90. PubMed ID: 15936756
[TBL] [Abstract][Full Text] [Related]
4. Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo.
Suryo Rahmanto Y; Dunn LL; Richardson DR
Carcinogenesis; 2007 Oct; 28(10):2172-83. PubMed ID: 17449903
[TBL] [Abstract][Full Text] [Related]
5. A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma.
Chen X; Lin J; Kanekura T; Su J; Lin W; Xie H; Wu Y; Li J; Chen M; Chang J
Cancer Res; 2006 Dec; 66(23):11323-30. PubMed ID: 17145878
[TBL] [Abstract][Full Text] [Related]
6. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
7. The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis.
Dunn LL; Sekyere EO; Suryo Rahmanto Y; Richardson DR
Carcinogenesis; 2006 Nov; 27(11):2157-69. PubMed ID: 16704991
[TBL] [Abstract][Full Text] [Related]
8. The human melanoma associated protein melanotransferrin promotes endothelial cell migration and angiogenesis in vivo.
Sala R; Jefferies WA; Walker B; Yang J; Tiong J; Law SK; Carlevaro MF; Di Marco E; Vacca A; Cancedda R; Cancedda FD; Ribatti D
Eur J Cell Biol; 2002 Nov; 81(11):599-607. PubMed ID: 12494997
[TBL] [Abstract][Full Text] [Related]
9. The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark--from iron metabolism to tumorigenesis.
Suryo Rahmanto Y; Dunn LL; Richardson DR
Oncogene; 2007 Sep; 26(42):6113-24. PubMed ID: 17452986
[TBL] [Abstract][Full Text] [Related]
10. H-cadherin expression reduces invasion of malignant melanoma.
Kuphal S; Martyn AC; Pedley J; Crowther LM; Bonazzi VF; Parsons PG; Bosserhoff AK; Hayward NK; Boyle GM
Pigment Cell Melanoma Res; 2009 Jun; 22(3):296-306. PubMed ID: 19368692
[TBL] [Abstract][Full Text] [Related]
11. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
Kim A; Kim MJ; Yang Y; Kim JW; Yeom YI; Lim JS
Carcinogenesis; 2009 Jun; 30(6):927-36. PubMed ID: 19336468
[TBL] [Abstract][Full Text] [Related]
12. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication.
Satyamoorthy K; Muyrers J; Meier F; Patel D; Herlyn M
Oncogene; 2001 Aug; 20(34):4676-84. PubMed ID: 11498790
[TBL] [Abstract][Full Text] [Related]
13. Role of ING4 in human melanoma cell migration, invasion and patient survival.
Li J; Martinka M; Li G
Carcinogenesis; 2008 Jul; 29(7):1373-9. PubMed ID: 18375955
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth.
Trisciuoglio D; Desideri M; Ciuffreda L; Mottolese M; Ribatti D; Vacca A; Del Rosso M; Marcocci L; Zupi G; Del Bufalo D
J Cell Physiol; 2005 Dec; 205(3):414-21. PubMed ID: 15920759
[TBL] [Abstract][Full Text] [Related]
15. Selection of invasive and metastatic subpopulations from a heterogeneous human melanoma cell line.
Seftor EA; Seftor RE; Hendrix MJ
Biotechniques; 1990 Sep; 9(3):324-31. PubMed ID: 2223075
[TBL] [Abstract][Full Text] [Related]
16. In vivo inhibition of angiogenesis by a soluble form of melanotransferrin.
Michaud-Levesque J; Demeule M; Béliveau R
Carcinogenesis; 2007 Feb; 28(2):280-8. PubMed ID: 16857721
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness.
Galaup A; Cazes A; Le Jan S; Philippe J; Connault E; Le Coz E; Mekid H; Mir LM; Opolon P; Corvol P; Monnot C; Germain S
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18721-6. PubMed ID: 17130448
[TBL] [Abstract][Full Text] [Related]
18. E2F1 in melanoma progression and metastasis.
Alla V; Engelmann D; Niemetz A; Pahnke J; Schmidt A; Kunz M; Emmrich S; Steder M; Koczan D; Pützer BM
J Natl Cancer Inst; 2010 Jan; 102(2):127-33. PubMed ID: 20026813
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
[TBL] [Abstract][Full Text] [Related]
20. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
